The economic impact of the transition from branded to generic oncology drugs.

作者: Winson Y. Cheung , Nicole Mittmann , Natasha B. Leighl , Matthew C. Cheung , Penelope Ann Bradbury

DOI: 10.1200/JCO.2016.34.15_SUPPL.6520

关键词: Public economicsEconomic impact analysisClinical trialOncology drugsMedicineComponent (UML)

摘要: 6520Background: Economic evaluations are an integral component of many clinical trials. Costs used in these analyses based on prices branded drugs when the agents first enter market. The imp...

参考文章(0)